Case Study 3: Eliquis Monitoring Litigation to Avoid a Budget Error When Bristol-Myers Squibb and Pfizers Eliquis (apixaban) initially faced generic competition expectations in 2026, payers and hospital systems began building budget models that assumed savings from generic apixaban starting that year
Ongoing monitoring, follow-up lab testing, and protocol adjustments are built into the program to optimize outcomes and maintain clinical precision
At Pulse and Remedy, we establish realistic expectations and monitoring timelines based on individual patient goals and circumstances
Non-Starchy Vegetables These nutrient-dense foods are packed with fiber, essential vitamins , and minerals, providing numerous health benefits
Bacterial growth is the secondary concern
Whether youre experiencing early signs of facial hollowing or more advanced changes, our solutions can help restore a youthful balance without surgery